Literature DB >> 32134484

Preventing Infection by Human Cytomegalovirus.

Stanley A Plotkin1.   

Abstract

The way to a successful vaccine against human cytomegalovirus is hampered by the peculiar biology of this infection. However, some candidate vaccines have been shown to protect seronegative women and transplant recipients, and we should know soon whether they can prevent congenital infection.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32134484      PMCID: PMC7057784          DOI: 10.1093/infdis/jiz448

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant.

Authors:  R F Pass; A M Duliegè; S Boppana; R Sekulovich; S Percell; W Britt; R L Burke
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

2.  Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants.

Authors:  Isabelle Boucoiran; Bryan T Mayer; Elizabeth M Krantz; Arnaud Marchant; Sunil Pati; Suresh Boppana; Anna Wald; Larry Corey; Corey Casper; Joshua T Schiffer; Soren Gantt
Journal:  Pediatr Infect Dis J       Date:  2018-07       Impact factor: 2.129

3.  Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors:  S D Elek; H Stern
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

Review 4.  Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.

Authors:  Daniele Lilleri; Giuseppe Gerna
Journal:  Rev Med Virol       Date:  2016-12-23       Impact factor: 6.989

5.  Perinatal Outcomes of Non-Primary Maternal Cytomegalovirus Infection: A 15-Year Experience.

Authors:  Giuliana Simonazzi; Alessandra Curti; Francesca Cervi; Liliana Gabrielli; Margherita Contoli; Maria Grazia Capretti; Nicola Rizzo; Brunella Guerra; Antonio Farina; Tiziana Lazzarotto
Journal:  Fetal Diagn Ther       Date:  2017-07-12       Impact factor: 2.587

6.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

Review 7.  Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity.

Authors:  William J Britt
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

8.  Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers.

Authors:  E Gonczol; J Ianacone; W Z Ho; S Starr; B Meignier; S Plotkin
Journal:  Vaccine       Date:  1990-04       Impact factor: 3.641

9.  Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.

Authors:  Steffanie Sabbaj; Robert F Pass; Paul A Goepfert; Sylvie Pichon
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

Review 10.  Vaccination against the human cytomegalovirus.

Authors:  Stanley A Plotkin; Suresh B Boppana
Journal:  Vaccine       Date:  2018-04-03       Impact factor: 3.641

View more
  6 in total

Review 1.  Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off?

Authors:  Ian J Groves; John H Sinclair; Mark R Wills
Journal:  Front Cell Infect Microbiol       Date:  2020-07-02       Impact factor: 5.293

Review 2.  Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward.

Authors:  Laura Olbrich; Lisa Stockdale; Robindra Basu Roy; Rinn Song; Luka Cicin-Sain; Elizabeth Whittaker; Andrew J Prendergast; Helen Fletcher; James A Seddon
Journal:  PLoS Pathog       Date:  2021-12-09       Impact factor: 6.823

3.  Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.

Authors:  Taylor Pursell; Jennifer L Spencer Clinton; Jie Tan; Rongsheng Peng; Paul D Ling
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

4.  An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine.

Authors:  Steffi Krauter; Nicole Büscher; Eric Bräuchle; Samira Ortega Iannazzo; Inessa Penner; Nadine Krämer; Patricia Gogesch; Simone Thomas; Marina Kreutz; Mario Dejung; Anja Freiwald; Falk Butter; Zoe Waibler; Bodo Plachter
Journal:  Vaccines (Basel)       Date:  2022-08-16

Review 5.  Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art.

Authors:  Susanna Esposito; Giulia Chiopris; Giulia Messina; Tiziana D'Alvano; Serafina Perrone; Nicola Principi
Journal:  Vaccines (Basel)       Date:  2021-05-19

6.  Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.

Authors:  Ian J Groves; Sarah E Jackson; Emma L Poole; Aharon Nachshon; Batsheva Rozman; Michal Schwartz; Rab K Prinjha; David F Tough; John H Sinclair; Mark R Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.